Tezepelumab reduced ocs use in ocs-dependent patients with severe asthma: phase 3b wayfinder study interim resultsD. J. Jackson,N. Lugogo, M. Gurnell,L. G. Heaney, S. Korn, G. Brusselle, P. Chanez, J-P Llanos, N. Martin, N. Keeling, K. Salapa, B. CookTHORAX（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
